Phase I study of neoadjuvant S‐1 plus cisplatin with concurrent radiation for biliary tract cancer (Tokyo Study Group for Biliary Cancer: TOSBIC02)

AIM: Neoadjuvant chemoradiotherapy may improve survival in patients with advanced cholangiocarcinoma. This Phase I study aimed to determine the recommended dose of neoadjuvant chemoradiotherapy and decide whether to move to a Phase II study. METHODS: Patients diagnosed with resectable stage II–IVa c...

Descripción completa

Detalles Bibliográficos
Autores principales: Abe, Yuta, Itano, Osamu, Takemura, Yusuke, Minagawa, Takuya, Ojima, Hidenori, Shinoda, Masahiro, Kitago, Minoru, Obara, Hideaki, Shigematsu, Naoyuki, Kitagawa, Yuko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472356/
https://www.ncbi.nlm.nih.gov/pubmed/37663959
http://dx.doi.org/10.1002/ags3.12682

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472356/
https://www.ncbi.nlm.nih.gov/pubmed/37663959
http://dx.doi.org/10.1002/ags3.12682

Ejemplares similares